BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21729933)

  • 1. New horizons for treatment of ANCA-associated vasculitides.
    Guillevin L; Mahr A
    Rheumatology (Oxford); 2012 Apr; 51(4):583-4. PubMed ID: 21729933
    [No Abstract]   [Full Text] [Related]  

  • 2. Extending the indications for rituximab in ANCA-associated vasculitis.
    Jayne D
    N Engl J Med; 2014 Nov; 371(19):1839-40. PubMed ID: 25372093
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
    Schönermarck U; Rau S; Fischereder M
    N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083401
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
    Nossent JC
    N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083400
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
    Hebert LA; Ardoin S; Shim RL
    N Engl J Med; 2010 Nov; 363(21):2072-3; author reply 2073-4. PubMed ID: 21083399
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rituximab to treat ANCA-associated vasculitis].
    Guillevin L; Mahr A
    Rev Med Interne; 2011 Oct; 32(10):591-3. PubMed ID: 21872370
    [No Abstract]   [Full Text] [Related]  

  • 7. S3. Rituximab for ANCA-associated vasculitides: the French experience.
    Charles P; Guillevin L
    Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
    [No Abstract]   [Full Text] [Related]  

  • 8. [ANCA-associated vasculitis].
    Holle JU
    Internist (Berl); 2015 Jan; 56(1):41-50; quiz 51-2. PubMed ID: 25502657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
    Chouchana L; Beaune P; Loriot MA
    N Engl J Med; 2015 Jan; 372(4):386. PubMed ID: 25607436
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
    Vandergheynst F
    N Engl J Med; 2015 Jan; 372(4):385-6. PubMed ID: 25607435
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
    Hebert LA; Alvarado A; Rovin B
    N Engl J Med; 2015 Jan; 372(4):385. PubMed ID: 25607434
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
    Pagnoux C; Guillevin L; ;
    N Engl J Med; 2015 Jan; 372(4):386-7. PubMed ID: 25607433
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of rituximab in the treatment of ANCA-associated vasculitides (AAV).
    Daikeler T; Kistler AD; Martin PY; Vogt B; Huynh-Do U
    Swiss Med Wkly; 2015; 145():w14103. PubMed ID: 25658140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
    Karassa FB
    N Engl J Med; 2010 Nov; 363(21):2073; author reply 2073-4. PubMed ID: 21083398
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab for ANCA-associated vasculitides.
    Guillevin L
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S118-21. PubMed ID: 24854382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
    Ntatsaki E; Carruthers D; Chakravarty K; D'Cruz D; Harper L; Jayne D; Luqmani R; Mills J; Mooney J; Venning M; Watts RA;
    Rheumatology (Oxford); 2014 Dec; 53(12):2306-9. PubMed ID: 24729399
    [No Abstract]   [Full Text] [Related]  

  • 17. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
    Jayne D
    Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
    Guillevin L; Pagnoux C; Karras A; Khouatra C; Aumaître O; Cohen P; Maurier F; Decaux O; Ninet J; Gobert P; Quémeneur T; Blanchard-Delaunay C; Godmer P; Puéchal X; Carron PL; Hatron PY; Limal N; Hamidou M; Ducret M; Daugas E; Papo T; Bonnotte B; Mahr A; Ravaud P; Mouthon L;
    N Engl J Med; 2014 Nov; 371(19):1771-80. PubMed ID: 25372085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
    Guerry MJ; Brogan P; Bruce IN; D'Cruz DP; Harper L; Luqmani R; Pusey CD; Salama AD; Scott DG; Savage CO; Watts RA; Jayne DR
    Rheumatology (Oxford); 2012 Apr; 51(4):634-43. PubMed ID: 21613248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ANCA-associated vasculitis ... 40 years later].
    Arazzi M
    G Ital Nefrol; 2013; 30(5):. PubMed ID: 24941484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.